Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Veralox Therapeutics, a US-based therapeutics developer exploiting technology from multiple academic research institutions, has raised $5.4m from seed investors including University of Maryland System’s Maryland Momentum Fund and University of Vermont’s Health Network. JRDF T1D Fund, managed by diabetes-focused charity JRDF, led the round with commitments from Virginia Tech Carilion (VTC) Innovation Fund and VTC…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.